Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,

Slides:



Advertisements
Similar presentations
The Role of Palliative Care in HIV/AIDS Management in Botswana
Advertisements

Part A: Module A5 Session 2
Vienna, Austria 4 September 2014 Stefano Berterame, Chief Narcotics Control and Estimates Section Secretariat of the International Narcotics Control Board.
Promoting Rational Use of Injections within National Medicine Policies World Health Organisation Dept. Essential Drugs and Medicines Policy Safe Injection.
Presentation to the 2014 International AIDS Conference
Human Rights and Palliative Care: A Primer Kiera Hepford Open Society Foundations Costing for Change Seminar Brasov, Romania October 26 th - 28 th, 2011.
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
EPECEPECEPECEPEC American Osteopathic Association AOA: Treating Our Family and Yours Osteopathic EPEC Osteopathic EPEC Education for Osteopathic Physicians.
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
The New World of Palliative Care State of Reform Conference January 8, 2015 Barbara Flye, American Cancer Society Cancer Action Network
Palliative Care and Human Rights Diederik Lohman.
IMPaCCT Standards for Paediatric Palliative Care in Europe Finella Craig Consultant in Paediatric Palliative Medicine The Louis Dundas Centre Great Ormond.
Seminar in Palliative Care September 26 – October 02, 2010 Salzburg, Austria in Collaboration with.
Palliative care and pain treatment in Zithulele Hospital and surrounding area 30 September 2011 Annette Dekker Health Grand Challenge Summer of Learning.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
June 11, IOM, Reducing Suicide, 2002 Statement of Task w Assess the science base w Evaluate the status of prevention w Consider strategies for studying.
Understanding and Using INCB Opioid Consumption Statistics: Including Morphine Equivalence 8 August 2012 Martha Maurer, MSW, MPH, PhD Pain & Policy Studies.
Current System of Drug Control In Georgia Prof. D. Kordzaia – Georgian National Association for Palliative Care VIENNA - March 5-6, 2013 “Making Oral Opioids.
“Improving opioid availability through advocacy” Experience from Serbia Snežana Bošnjak International Pain Policy Fellow ( ) Institute for Oncology.
WHO Access to Controlled Medications Programme & Ensuring balance in national policies on controlled substances Barbara Milani, Technical Officer Department.
Colombia’s Cooperation Strategy with the Caribbean Basin Partners 25 Colombia Caribbean Countries Antigua and Barbuda, Bahamas, Barbados, Belize, Costa.
Palliative Care: a Key Component of Care
Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Medicines and Service Availability and Accessibility in Cancer Care in Georgia 28 th August 2012 Tbilisi Tamari Rukhadze MD. PhD. Oncologist, International.
Institut Català d’Oncologia ICO DiR. The ‘Qualy’ End of Life Care Observatory - WHO Collaborating Centre for Public Health Palliative Care Programmes Central.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
“” “Balance” Jim Cleary, MD Associate Professor of Medicine Director, Palliative Care Medicine, UW Hospital & Clinics Director, WHO Collaborating Center.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
+ Role of Industry in Clinical Care, Research, and Education.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Update and Clarifications Regarding Local Pharmaceutical Assistance Programs Susan Robilotto, D.O. Clinical Consultant/ Medical Officer Department of Health.
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
National Consensus Project and Clinical Practice Guidelines Kelli Gershon, MSN, APRN, BC-PCM Palliative Care The University of Texas M.D.Anderson Cancer.
Matsievskaya Larissa Leonardovna Karaganda 2014 Karaganda State Medical University Department foundations of psychology and communicative skills.
"Perspectives of former International Pain Policy Fellows" Prof. Snežana Bošnjak, MD, PhD Institute for Oncology and Radiology of Serbia (IORS) Belgrade,
Where we come from EFIC 2001, Human Rights Watch 2009, IASP 2010, SIP 2010/2011 Where we are Roadmap Monitor 2011/2012 Where we want to go The Societal.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
 Agreed upon fees paid for coverage of medical benefits for a defined benefit period. Premiums can be paid by employers, unions, employees, or shared.
Introduction to pain Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
Introduction to Palliative Care Jigar Joshi MBBS Hospice and Palliative Medicine Fellow.
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
Gilberto Gerra Drug Prevention and Health Branch Access to controlled drugs for medical purposes: a commitment for the international community.
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )
Jesse Stoff Ensures Good Health Through Quality Health Care Services.
Testimony of Sidney Wolfe, M.D. Health Research Group of Public Citizen FDA Drug Safety and Risk Management and Anesthetic and Analgesic Drug Products.
Health Care Management Dr. Sireen Alkhaldi, BDS, MPH, DrPH Community Health / First Semester 2014/2015 Department of Family and Community Medicine Faculty.
Issues in Palliative Sedation Bruce A. Ferrell, MD Professor of Clinical Medicine UCLA David Geffen School of Medicine Director of Palliative Care.
Nurs Dip, BSc Nurs, PGDIP Palliative care
Declaration of Miami Joining forces for better pain treatment and promotion of pain medicine throughout the world.
Legal and Regulatory Issues in Pain Management
Palliative Care in Canada: History, Vision and Challenges
Canada Needs PAs.
ROOM project Addressing the Opioid Epidemic in the U.P.
Indispensable, adequately provided and not unduly restricted
What is palliative care?
Canada Needs PAs.
Canada Needs PAs.
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Canada Needs PAs.
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Canada Needs PAs.
Presentation transcript:

Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director, Joint Centre for Bioethics, University of Toronto Cancer Pain Physician, Princess Margaret Hospital, Toronto

Objectives 1.Cancer pain management as a human right 2.Relationship with industry & pain

Pain Management as a Human Right IASP Montreal Declaration IASP Montreal Declaration  Declaration that access to pain management is a fundamental human right  Means that there is an ethical & probably legal requirement to act

IASP Montreal Declaration Pain management is inadequate in most of the world because of: Pain management is inadequate in most of the world because of:  Inadequate access to treatment  Failure to recognize that chronic pain is a serious chronic health problem

IASP Montreal Declaration Pain management is inadequate in most of the world because of: Pain management is inadequate in most of the world because of:  Major deficits in knowledge of health care professionals regarding the mechanisms & management of pain  Chronic pain with or without diagnosis is highly stigmatized

IASP Montreal Declaration Pain management inadequate in most of the world because: Pain management inadequate in most of the world because: Most countries have no national policy at all or very inadequate policies regarding the management of pain as a health problem, including an inadequate level of research & education Most countries have no national policy at all or very inadequate policies regarding the management of pain as a health problem, including an inadequate level of research & education  Pain Medicine is not recognized as a distinct specialty with a unique body of knowledge & defined scope of practice founded on research & comprehensive training programs

IASP Montreal Declaration Pain management is inadequate in most of the world because: Pain management is inadequate in most of the world because:  World Health Organization (WHO) estimates that 5 billion people live in countries with low or no access to controlled medicines and have no or insufficient access to treatment for moderate to severe pain  There are severe restrictions on the availability of opioids & other essential medications, critical to the management of pain

Pain Management as a Human Right Human Rights Watch Human Rights Watch  Global State of Pain Treatment & Access to Palliative Care as a Human Right

Pain Management as a Human Right-HRW Every year, tens of millions of people around the world with life-threatening illnesses suffer unnecessarily from severe pain and other debilitating symptoms because they lack access to palliative care, an inexpensive health service that aims to improve the quality of life of people with serious health conditions Every year, tens of millions of people around the world with life-threatening illnesses suffer unnecessarily from severe pain and other debilitating symptoms because they lack access to palliative care, an inexpensive health service that aims to improve the quality of life of people with serious health conditions

In Central America and the Caribbean, about half of the countries consume so few opioid medications that even if all were used exclusively to treat patients with terminal cancer and HIV for pain, less than a third of them could receive adequate treatment (Belize, El Salvador, Honduras, Nicaragua, Saint Kitts and Nevis, Trinidad and Tobago, Jamaica, Dominican Republic, and Haiti) In Central America and the Caribbean, about half of the countries consume so few opioid medications that even if all were used exclusively to treat patients with terminal cancer and HIV for pain, less than a third of them could receive adequate treatment (Belize, El Salvador, Honduras, Nicaragua, Saint Kitts and Nevis, Trinidad and Tobago, Jamaica, Dominican Republic, and Haiti)

**T&T has 1/20 the population of Canada

INCB Report Need to achieve a balance between ensuring availability of internationally controlled substances for medical and scientific purposes and preventing their diversion and abuse Need to achieve a balance between ensuring availability of internationally controlled substances for medical and scientific purposes and preventing their diversion and abuse

INCB Report The Board considers all levels of consumption of narcotic drugs below 200 S-DDD per million inhabitants per day inadequate. However, this does not imply that levels above 200 S-DDD can be considered adequate as the determination of whether availability of internationally controlled substances required for treatment is sufficient depends on the specific morbidity data The Board considers all levels of consumption of narcotic drugs below 200 S-DDD per million inhabitants per day inadequate. However, this does not imply that levels above 200 S-DDD can be considered adequate as the determination of whether availability of internationally controlled substances required for treatment is sufficient depends on the specific morbidity data

Websites  Multiple videos & reports  Video “Life Before Death” s/AnnualReports/AR10_Supp_E.pdf s/AnnualReports/AR10_Supp_E.pdf s/AnnualReports/AR10_Supp_E.pdf s/AnnualReports/AR10_Supp_E.pdf

PAIN AND INDUSTRY: ETHICS

How to dance with porcupines: rules and guidelines on doctors’ relations with drug companies BMJ 2003 How to dance with porcupines: rules and guidelines on How to dance with porcupines: rules and guidelines on doctors’ relations with drug companies doctors’ relations with drug companies

Pharmaceutical Industry & Opioid Availability Expensive sustained-release opioids seem to be making an appearance on formularies when cheaper alternatives like immediate- release & injectable morphine & hydromorphone are not allowed or in very limited supply in many countries Expensive sustained-release opioids seem to be making an appearance on formularies when cheaper alternatives like immediate- release & injectable morphine & hydromorphone are not allowed or in very limited supply in many countries  Sometimes companies abandon markets

Influence of Pharmaceutical Industry on Pain Professionals Clinical research funding in pain to a great extent funded by industry Clinical research funding in pain to a great extent funded by industry Conference support by industry is absolutely necessary for those conferences to take place Conference support by industry is absolutely necessary for those conferences to take place  Glossy booths for industry Speakers bureaus & consultant contracts Speakers bureaus & consultant contracts

Influence of Pharmaceutical Industry on Pain Professionals Articles mostly funded by industry & many ghostwritten Articles mostly funded by industry & many ghostwritten Research often multicentric & may be in jurisdictions where research ethics boards or independent boards have lower standards Research often multicentric & may be in jurisdictions where research ethics boards or independent boards have lower standards Data not made available to researchers Data not made available to researchers

Summary There is much to do in relieving cancer pain There is much to do in relieving cancer pain Pain relief is a human right Pain relief is a human right Availability of opioids around the globe is an issue Availability of opioids around the globe is an issue The availability of opioids in T&T is very limited & needed drugs are all generic The availability of opioids in T&T is very limited & needed drugs are all generic